HRCVX
Price
$22.81
Change
+$0.24 (+1.06%)
Updated
Dec 3 closing price
Net Assets
523.87M
VVIAX
Price
$74.33
Change
+$0.66 (+0.90%)
Updated
Dec 3 closing price
Net Assets
207.95B
Interact to see
Advertisement

HRCVX vs VVIAX

Header iconHRCVX vs VVIAX Comparison
Open Charts HRCVX vs VVIAXBanner chart's image
Carillon Eagle Growth & Income A
Price$22.81
Change+$0.24 (+1.06%)
VolumeN/A
Net Assets523.87M
Vanguard Value Index Adm
Price$74.33
Change+$0.66 (+0.90%)
VolumeN/A
Net Assets207.95B
HRCVX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
HRCVX vs. VVIAX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRCVX is a StrongBuy and VVIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 208B vs. HRCVX (524M). VVIAX pays higher dividends than HRCVX: VVIAX (2.04) vs HRCVX (1.09). HRCVX was incepted earlier than VVIAX: HRCVX (39 years) vs VVIAX (25 years). HRCVX (0.97) is less costly to investors than VVIAX (0.05). HRCVX is a more actively managed with annual turnover of: 40.00 vs. VVIAX (9.00). HRCVX has a lower initial minimum investment than VVIAX: HRCVX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 6.10 vs. HRCVX (-5.91). VVIAX return over 5 years is better than : 60.40 vs. HRCVX (7.10).
HRCVXVVIAXHRCVX / VVIAX
Total Expense Ratio0.970.051,940%
Annual Report Gross Expense Ratio0.970.051,940%
Fund Existence39 years25 years-
Gain YTD13.28212.640105%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets524M208B0%
Annual Yield % from dividends1.092.0453%
Returns for 1 year-5.916.10-97%
Returns for 3 years1.9730.826%
Returns for 5 years7.1060.4012%
Returns for 10 years47.60128.9037%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALLO1.520.18
+13.43%
Allogene Therapeutics
BCAB0.830.05
+6.00%
BioAtla
AGIO27.490.51
+1.89%
Agios Pharmaceuticals
WTGUU10.30N/A
N/A
Wintergreen Acquisition Corp.
UGI37.64-0.49
-1.29%
UGI Corp